FDA Approves Trodelvy for HER2-Negative, HR-Positive Metastatic Breast Cancer
Momelotinib Continues to Demonstrate Symptom Benefit for Patients With Myelofibrosis
Medicaid Expansion Associated With Improved Breast Cancer Outcomes
Despite Rapid Increase in Immunotherapy Use for Lung Cancer, Survival Benefit for Older Patients Is Modest